MoneyWorks4Me

Glenmark Pharmaceuticals board to consider unaudited financial statements

18 Jan 2013 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on January 29, 2013, to consider and approve the company’s un-audited financial statements for the Third Quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..